199 related articles for article (PubMed ID: 15894813)
1. Bone-specific alkaline phosphatase activity is inhibited by bisphosphonates: role of divalent cations.
Vaisman DN; McCarthy AD; Cortizo AM
Biol Trace Elem Res; 2005 May; 104(2):131-40. PubMed ID: 15894813
[TBL] [Abstract][Full Text] [Related]
2. Structurally different bisphosphonates exert opposing effects on alkaline phosphatase and mineralization in marrow osteoprogenitors.
Klein BY; Ben-Bassat H; Breuer E; Solomon V; Golomb G
J Cell Biochem; 1998 Feb; 68(2):186-94. PubMed ID: 9443074
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.
Reinholz GG; Getz B; Pederson L; Sanders ES; Subramaniam M; Ingle JN; Spelsberg TC
Cancer Res; 2000 Nov; 60(21):6001-7. PubMed ID: 11085520
[TBL] [Abstract][Full Text] [Related]
4. Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells.
Gangoiti MV; Cortizo AM; Arnol V; Felice JI; McCarthy AD
Eur J Pharmacol; 2008 Dec; 600(1-3):140-7. PubMed ID: 18973752
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of osteoblast function in vitro by aminobisphosphonates.
Orriss IR; Key ML; Colston KW; Arnett TR
J Cell Biochem; 2009 Jan; 106(1):109-18. PubMed ID: 19003973
[TBL] [Abstract][Full Text] [Related]
6. Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase.
Stresing V; Fournier PG; Bellahcène A; Benzaïd I; Mönkkönen H; Colombel M; Ebetino FH; Castronovo V; Clézardin P
Bone; 2011 Feb; 48(2):259-66. PubMed ID: 20920623
[TBL] [Abstract][Full Text] [Related]
7. Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy.
Leu CT; Luegmayr E; Freedman LP; Rodan GA; Reszka AA
Bone; 2006 May; 38(5):628-36. PubMed ID: 16185944
[TBL] [Abstract][Full Text] [Related]
8. Strontium ranelate stimulates the activity of bone-specific alkaline phosphatase: interaction with Zn(2+) and Mg (2+).
Fernández JM; Molinuevo MS; McCarthy AD; Cortizo AM
Biometals; 2014 Jun; 27(3):601-7. PubMed ID: 24737106
[TBL] [Abstract][Full Text] [Related]
9. Nitrogen-containing bisphosphonate mechanism of action.
Reszka AA; Rodan GA
Mini Rev Med Chem; 2004 Sep; 4(7):711-9. PubMed ID: 15379639
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
Russell RG; Xia Z; Dunford JE; Oppermann U; Kwaasi A; Hulley PA; Kavanagh KL; Triffitt JT; Lundy MW; Phipps RJ; Barnett BL; Coxon FP; Rogers MJ; Watts NB; Ebetino FH
Ann N Y Acad Sci; 2007 Nov; 1117():209-57. PubMed ID: 18056045
[TBL] [Abstract][Full Text] [Related]
11. The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells.
Ishtiaq S; Edwards S; Sankaralingam A; Evans BA; Elford C; Frost ML; Fogelman I; Hampson G
Cytokine; 2015 Feb; 71(2):154-60. PubMed ID: 25461393
[TBL] [Abstract][Full Text] [Related]
12. Regulation of alkaline phosphatase: implications for calcium pyrophosphate dihydrate crystal dissolution and other alkaline phosphatase functions.
Shinozaki T; Pritzker KP
J Rheumatol; 1996 Apr; 23(4):677-83. PubMed ID: 8730126
[TBL] [Abstract][Full Text] [Related]
13. [Influence of Zn++ and of Mg++ on alkaline phosphatase activity of different origins].
Casey H; Zanobini A; Firenzuoli AM; Treves C; Bianchi A
Boll Soc Ital Biol Sper; 1980 Jan; 56(2):108-14. PubMed ID: 7002169
[TBL] [Abstract][Full Text] [Related]
14. Degradable bisphosphonate-alkaline phosphatase-complexed hydroxyapatite implants in vitro.
Denissen H; van Beek E; van den Bos T; de Blieck J; Klein C; van den Hooff A
J Bone Miner Res; 1997 Feb; 12(2):290-7. PubMed ID: 9041063
[TBL] [Abstract][Full Text] [Related]
15. Effects of the bisphosphonate zoledronate on bone loss in the ovariectomized and in the adjuvant arthritic rat.
Müller K; Wiesenberg I; Jaeggi K; Green JR
Arzneimittelforschung; 1998 Jan; 48(1):81-6. PubMed ID: 9522039
[TBL] [Abstract][Full Text] [Related]
16. Uptake of nickel from 316L stainless steel into contacting osteoblastic cells and metal ion interference with BMP-2-induced alkaline phosphatase.
Mölders M; Felix J; Bingmann D; Hirner A; Wiemann M
J Biomed Mater Res A; 2007 Nov; 83(2):303-12. PubMed ID: 17437303
[TBL] [Abstract][Full Text] [Related]
17. [In vitro study of the effect of bisphosphonates on mineralization induced by a composite material: poly 2(hydroxyethyl) methacrylate coupled with alkaline phosphatase].
Filmon R; Baslé MF; Barbier A; Chappard D
Morphologie; 2000 Mar; 84(264):23-33. PubMed ID: 10923337
[TBL] [Abstract][Full Text] [Related]
18. Effects of zinc on the mineralization of bone nodules from human osteoblast-like cells.
Cerovic A; Miletic I; Sobajic S; Blagojevic D; Radusinovic M; El-Sohemy A
Biol Trace Elem Res; 2007 Apr; 116(1):61-71. PubMed ID: 17634628
[TBL] [Abstract][Full Text] [Related]
19. Indirect antitumor effects of bisphosphonates on prostatic LNCaP cells co-cultured with bone cells.
Tanaka T; Kawashima H; Ohnishi K; Matsumura K; Yoshimura R; Matsuyama M; Kuratsukuri K; Nakatani T
Anticancer Res; 2009 Apr; 29(4):1089-94. PubMed ID: 19414350
[TBL] [Abstract][Full Text] [Related]
20. Analytical and clinical evaluation of a method to quantify bone alkaline phosphatase, a marker of osteoblastic activity.
Martin M; Van Hoof V; Couttenye M; Prove A; Blockx P
Anticancer Res; 1997; 17(4B):3167-70. PubMed ID: 9329628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
